Allergan and Richter Announce Positive Topline Results from Phase III Study of Cariprazine for the Treatment of Bipolar I Depression
12/18/2017
Business related R&D trial Central Nervous System PARTNER - ALLERGAN / ABBVIE / ACTAVIS PRODUCT - VRAYLAR API - CARIPRAZINE